Table 3.
Limitation | ||||||
---|---|---|---|---|---|---|
Mechanical Ventilation |
Renal Replacement Therapy |
Nutrition | Hydration | Vasopressors | Any | |
Patients with Treatment Limitation, Number (%) |
18 (8.9) | 30 (15.0) | 18 (8.9) | 18 (8.9) | 32 (15.8) | 39 (19.2) |
Mortalitya, N (%) | 14 (77.8) | 25 (83.3) | 15 (83.3) | 15 (83.3) | 27 (84.4) | 31 (79.5) |
Time to Treatment Limitation |
||||||
Hospital Admission to Limitationb, median days (IQR) |
39.0 (31.0–45.0) | 40.0 (26.0–61.0) | 46.5 (29.0–60.0) | 41.0 (25.0–60.0) | 39.0 (26.0–61.0) | |
RCU Admission to Limitationc, median days (IQR) |
19.0 (13.0–26.0) | 14.5 (9.0–30.0) | 20.5 (13.0–30.0) | 19.0 (13.0–30.0) | 13.0 (8.0–29.0) | |
Time from Limitation to Deathd |
||||||
Median days (IQR) | 3.0 (0.0–9.0) | 7.0 (4.0–11.5) | 4.0 (1.0–7.0) | 3.0 (0.0–7.0) | 5.0 (1.0–11.0) |
Patients with treatment limitation who died in the hospital (categories are not mutually exclusive);
Number of days from hospital admission to first treatment limitation;
Number of days from RCU admission to first treatment limitation;
For those patients who had treatment limited and died in the hospital, number of days from first limitation to death.